This filing is purely procedural with no trading implications. Monitor upcoming quarterly earnings or material events for actionable signals.
Price Chart
Executive Summary
Dr. Reddy's Laboratories filed a routine Form 6-K on October 23, 2026, furnishing an intimation letter (Exhibit 99.1) to the SEC. The filing contains no new material financial disclosures, earnings data, or operational updates beyond what was previously reported in its annual 20-F filing from May 2026. This is a standard administrative submission for a foreign private issuer.
Key Facts
- Filed Form 6-K on October 23, 2026, as a report of foreign private issuer under Rules 13a-16 and 15d-16.
- Exhibit 99.1 is an intimation dated October 23, 2026; no financial figures or material events are disclosed in the filing text.
- The filing references the company's annual report on Form 20-F (filed May 29, 2026) and confirms no material changes since that report.
- No revenue, earnings, guidance, M&A, regulatory actions, or other material business developments are reported.
Financial Impact
No financial impact, the filing is administrative with no new financial data.
Risk Factors
- No new risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001575872-26-000721 |
| Document: 0001575872-26-000721-index.html | 0001575872-26-000721 |
| Document: 0001575872-26-000721.txt | 0001575872-26-000721 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 2d ago | 6-K | $13.75 | awaiting T+5 | awaiting T+5 | $14.17 (+3.05%) |
Oct 26, 2026 2d ago | 6-K | $13.75 | awaiting T+5 | awaiting T+5 | $14.17 (+3.05%) |
Oct 23, 2026 4d ago | 6-K | $13.21 | awaiting T+5 | awaiting T+5 | $14.17 (−7.27%) |
Oct 23, 2026 4d ago | 6-K | $13.21 | awaiting T+5 | awaiting T+5 | $14.17 (+7.27%) |
Oct 23, 2026 4d ago | 6-K | $13.21 | awaiting T+5 | awaiting T+5 | $14.17 (+7.27%) |
Oct 23, 2026 4d ago | 6-K | $13.21 | awaiting T+5 | awaiting T+5 | $14.17 (−7.27%) |
Oct 21, 2026 7d ago | 6-K | $13.19 | awaiting T+5 | awaiting T+5 | $14.17 (+7.43%) |
Oct 14, 2026 13d ago | 6-K | $12.75 $13.19 | ▲ +3.45% | ▲ +3.00% | $14.17 (+11.14%) |
Oct 8, 2026 20d ago | 6-K | $12.20 $12.90 | ▲ +5.74% | ▲ +6.01% | $14.17 (+16.15%) |
Oct 7, 2026 21d ago | 6-K | $12.27 $12.75 | ▲ +3.91% | ▲ +4.89% | $14.17 (+15.48%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers